Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153165 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-02-10 | 2022-07-01 | 154720 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2022-04-28 | 2022-07-01 | 159590 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2024-05-03 | 198292 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-10-19 | 2024-05-09 | 207512 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2020-08-27 | 2020-09-17 | 123087 |
| TEVA-INDOMETHACIN | 50MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126924 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2021-03-25 | 2021-04-15 | 136320 |
| TEVA-INDOMETHACIN | 25MG | CAPSULE | Resolved | 2022-10-17 | 2023-06-09 | 172010 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2019-08-22 | 2019-11-14 | 92148 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2020-02-07 | 2020-05-08 | 105576 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124974 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134334 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2021-07-15 | 2021-08-13 | 142625 |
| TEVA-IMATINIB | 100MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174613 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |